Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 2Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Pneumonia, Pneumococcal 1Neoplasms, Plasma Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Heptavalent Pneumococcal Conjugate Vaccine × Clear all
NCT01245673 2020-04-06

Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma

University of Pennsylvania

Phase 2 Completed
28 enrolled 8 charts
Plasma cell

Neoplasms, Plasma Cell

NCT00323557 2012-12-05

Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients

M.D. Anderson Cancer Center

Phase 2 Completed
39 enrolled 4 charts
LymphoidOther hematologic neoplasm

Leukemia, Pneumonia, Pneumococcal, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡